Public funding and pricing
Public funding and pricing The Norwegian Medical Products Agency is responsible for assessing the cost-effectiveness of prescription-only-medicines and for setting maximum prices.
Call for tender: Assessment of the health opportunity cost in Norway
Published:
Increased focus on joint European health technology assessments
Published:
|
Updated:
NOMA director new head of European health technology assessment network
Published:
Important information regarding preparation of documentation packages for health technology assessments
Published: